Skip to main content

Share story

Capital

Nyne raises $5.3M seed funding

Nyne raises $5.3M seed funding Image: Primary
Nyne announced Friday that it raised 5.3 million dollars in seed funding. The round was led by Wischoff Ventures and South Park Commons. Several angel investors participated, including Gil Elbaz, co-founder of Applied Semantics and a pioneer of Google AdSense. The company was founded by chief executive Michael Fanous, a UC Berkeley computer science graduate and former machine learning engineer at CareRev, and his father Emad Fanous, a veteran chief technology officer. Nyne aims to serve as an intelligence layer that helps AI agents understand humans by analyzing public digital footprints across platforms. Fanous said Nyne deploys millions of agents across the internet to analyze public data from major social networks and apps such as SoundCloud and Strava. It then applies machine learning techniques to triangulate information about individuals. He noted that the approach addresses a gap left by companies like Google, which do not share their proprietary search and cross-platform data with external agents. Nichole Wischoff, founder of Wischoff Ventures, said the market for this type of data is massive for any company using AI agents to reach customers. Fanous added that the data can reveal interests, hobbies, and specific thinking patterns to inform agent actions.
Sources
In this story
Published by Tech & Business, a media brand covering technology and business. This story was sourced from TechCrunch and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Capital
Capital

Nominal raises $240 million at a $3 billion valuation

Nominal has raised $240 million at a $3 billion valuation, triple its valuation in a funding round earlier this year, Bloomberg reports. The startup builds software to make manufacturing more efficient.

Capital Products
Capital Products

Onodrim raises $300M to acquire European defence and industrial suppliers

Amsterdam-based Onodrim Industries has raised $300M in a round led by Lux Capital, valuing the defence group at $1.3bn, the company said Monday. Other investors include General Catalyst, Lakestar and Altimeter. The financing follows its €40M seed round in February.

Capital
Capital

SRTD Biotech raises €31.5 million for targeted RNA therapies

SRTD Biotech has completed an oversubscribed €31.5 million seed financing to develop RNA therapies designed to act selectively inside diseased cells. Mérieux Equity Partners led the round, with NRW.BANK and Boehringer Ingelheim Venture Fund joining as co-leads.